Literature DB >> 7815423

Congenital contractural arachnodactyly (Beals syndrome).

D Viljoen1.   

Abstract

Congenital contractural arachnodactyly (CCA) is an autosomal dominant disorder akin to, but usually less severe than, Marfan syndrome. The clinical features are marfanoid habitus, arachnodactyly, crumpled ears, camptodactyly of the fingers and adducted thumbs, mild contractures of the elbows, knees, and hips, and mild muscle hypoplasia especially of the calf muscles. Many patients have kyphoscoliosis and mitral valve prolapse and, very occasionally, aortic root dilatation and ectopia lentis have been described. Linkage to a gene coding for fibrillin on chromosome 5q23-31 has been shown in several kindreds. The prognosis for a normal lifespan is good and improvement in joint contractures is usual.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7815423      PMCID: PMC1050028          DOI: 10.1136/jmg.31.8.640

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  11 in total

1.  Congenital contractural arachnodactyly in a black family.

Authors:  N L Steg
Journal:  Birth Defects Orig Artic Ser       Date:  1975

2.  Ectopia lentis and aortic root dilatation in congenital contractural arachnodactyly.

Authors:  E Bawle; M H Quigg
Journal:  Am J Med Genet       Date:  1992-01-01

3.  "New" syndrome of congenital contractural arachnodactyly originally described by Marfan in 1896.

Authors:  F Hecht; R K Beals
Journal:  Pediatrics       Date:  1972-04       Impact factor: 7.124

4.  Location on chromosome 15 of the gene defect causing Marfan syndrome.

Authors:  K Kainulainen; L Pulkkinen; A Savolainen; I Kaitila; L Peltonen
Journal:  N Engl J Med       Date:  1990-10-04       Impact factor: 91.245

5.  Beals syndrome: clinical and molecular investigations in a kindred of Indian descent.

Authors:  D Viljoen; R Ramesar; D Behari
Journal:  Clin Genet       Date:  1991-03       Impact factor: 4.438

6.  Congenital contractural arachnodactyly, keratoconus, and probable Marfan syndrome in the same pedigree.

Authors:  H N Bass; R S Sparkes; B F Crandall; S M Marcy
Journal:  J Pediatr       Date:  1981-04       Impact factor: 4.406

7.  Congenital contractural arachnodactyly. Report of four additional families and review of literature.

Authors:  M A Ramos Arroyo; D D Weaver; R K Beals
Journal:  Clin Genet       Date:  1985-06       Impact factor: 4.438

8.  A severe form of congenital contractural arachnodactyly in two newborn infants.

Authors:  G Currarino; J M Friedman
Journal:  Am J Med Genet       Date:  1986-12

9.  Contractural arachnodactyly with mitral regurgitation and iridodonesis.

Authors:  I C Huggon; J P Burke; J F Talbot
Journal:  Arch Dis Child       Date:  1990-03       Impact factor: 3.791

10.  Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes.

Authors:  B Lee; M Godfrey; E Vitale; H Hori; M G Mattei; M Sarfarazi; P Tsipouras; F Ramirez; D W Hollister
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

View more
  14 in total

1.  Fibrillin-containing microfibrils are key signal relay stations for cell function.

Authors:  Karina A Zeyer; Dieter P Reinhardt
Journal:  J Cell Commun Signal       Date:  2015-10-08       Impact factor: 5.782

Review 2.  The molecular genetics of Marfan syndrome and related microfibrillopathies.

Authors:  P N Robinson; M Godfrey
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

3.  Fibrillin-3 expression in human development.

Authors:  Laetitia Sabatier; Nicolai Miosge; Dirk Hubmacher; Guoqing Lin; Elaine C Davis; Dieter P Reinhardt
Journal:  Matrix Biol       Date:  2010-10-21       Impact factor: 11.583

4.  A rare branch-point mutation is associated with missplicing of fibrillin-2 in a large family with congenital contractural arachnodactyly.

Authors:  C Maslen; D Babcock; M Raghunath; B Steinmann
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

Review 5.  The molecular genetics of Marfan syndrome and related disorders.

Authors:  P N Robinson; E Arteaga-Solis; C Baldock; G Collod-Béroud; P Booms; A De Paepe; H C Dietz; G Guo; P A Handford; D P Judge; C M Kielty; B Loeys; D M Milewicz; A Ney; F Ramirez; D P Reinhardt; K Tiedemann; P Whiteman; M Godfrey
Journal:  J Med Genet       Date:  2006-03-29       Impact factor: 6.318

6.  Fibrillin-2 is dispensable for peripheral nerve development, myelination and regeneration.

Authors:  Michael A Chernousov; Kelly Baylor; Richard C Stahl; Mark M Stecker; Lynn Y Sakai; Sui Lee-Arteaga; Francesco Ramirez; David J Carey
Journal:  Matrix Biol       Date:  2010-02-25       Impact factor: 11.583

7.  ENU mutagenesis reveals a novel phenotype of reduced limb strength in mice lacking fibrillin 2.

Authors:  Gaynor Miller; Monica Neilan; Ruth Chia; Nabeia Gheryani; Natalie Holt; Annabelle Charbit; Sara Wells; Valter Tucci; Zuzanne Lalanne; Paul Denny; Elizabeth M C Fisher; Michael Cheeseman; Graham N Askew; T Neil Dear
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

8.  Congenital contractural arachnodactyly (Beals-Hecht syndrome): a rare connective tissue disorder.

Authors:  Alexander Jurko; Jana Krsiakova; Milan Minarik; Ingrid Tonhajzerova
Journal:  Wien Klin Wochenschr       Date:  2013-04-18       Impact factor: 1.704

9.  A child with Myhre syndrome presenting with corectopia and tetralogy of Fallot.

Authors:  Marianna Alagia; Gerarda Cappuccio; Michele Pinelli; Annalaura Torella; Raffaella Brunetti-Pierri; Francesca Simonelli; Giuseppe Limongelli; Guido Oppido; Vincenzo Nigro; Nicola Brunetti-Pierri
Journal:  Am J Med Genet A       Date:  2017-12-12       Impact factor: 2.802

10.  Identification of a Novel Missense FBN2 Mutation in a Chinese Family with Congenital Contractural Arachnodactyly Using Exome Sequencing.

Authors:  Hao Deng; Qian Lu; Hongbo Xu; Xiong Deng; Lamei Yuan; Zhijian Yang; Yi Guo; Qiongfen Lin; Jingjing Xiao; Liping Guan; Zhi Song
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.